Argus Investors Counsel’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
BCM
Argus Investors Counsel's TECH Position: Q1 2023 in Review
Argus Investors Counsel sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 17,106 shares — an estimated $1.42M sold.
Argus Investors Counsel first reported a position in TECH in Q3 2018 and held it in 18 quarters. The position peaked at $1.87M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.
- Argus Investors Counsel reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
- Argus Investors Counsel sold 17,106 Bio-Techne shares in Q1 2023, an estimated $1.42M.
- Argus Investors Counsel first reported a position in Bio-Techne in Q3 2018 and held it in 18 quarters.
- Argus Investors Counsel's Bio-Techne position peaked at $1.87M in Q4 2021.
- 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.
Based on Argus Investors Counsel's 13F filing for Q1 2023, filed 20 Apr 2023.